Bioxytran, Inc
BIXT· OTC
BIXTBioxytran, Inc
Filed Mar 31, 2023 · 10-K · 90 days after period end · 0001493152-23-010104
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$754.56K | -$998.40K | -$871.39K | -$662.66K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 31, 2023 · 90 d after period end
